Oncopeptides AB (publ) announced that CEO Monica Shaw will be departing the company and transition over to Sofia Heigis who will move from the CCO role to take on the CEO role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 SEK | +4.08% |
|
0.00% | -55.09% |
May. 30 | Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank | MT |
May. 30 | Transcript : Oncopeptides AB, Q1 2024 Earnings Call, May 30, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.09% | 70.65M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+4.40% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-15.36% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Announces Executive Changes